Home › Liver Diseases › Ohio › Akron
Liver Diseases clinical trials in Akron, OH
3 studies for Liver Diseases are looking for participants at sites in and around Akron (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
RecruitingPhase 2
- Akron Gastro Research, Akron
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
RecruitingPhase 3
- 89bio Clinical Study Site, Akron
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
RecruitingPhase 3
- 89bio Clinical Study Site, Akron
About Liver Diseases
Get the facts about liver diseases, such as hepatitis, cancer, and cirrhosis. Know your risk and what you can do to prevent liver problems.
More about Liver Diseases on MedlinePlus
Liver Diseases trials in other cities
- Chicago, IL10 studies
- Houston, TX10 studies
- Los Angeles, CA8 studies
- Washington, DC8 studies
- Atlanta, GA8 studies
- New York City, NY7 studies
- San Antonio, TX6 studies
- Philadelphia, PA6 studies
- Richmond, VA6 studies
- Durham, NC5 studies
- Ann Arbor, MI5 studies
- Aurora, CO5 studies
Other studies in Akron
- Non-Small Cell Lung Cancer22 studies
- Lung Cancer16 studies
- Cancer (all types)14 studies
- Breast Cancer13 studies
- Prostate Cancer9 studies
- Metastatic Cancer8 studies
- Colorectal Cancer8 studies
- Melanoma8 studies
- Acute Myeloid Leukemia8 studies
- Small Cell Lung Cancer8 studies
- Endometrial Cancer7 studies
- Steatotic Liver Disease7 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.